Insights

Strategic partnerships Genomate Health is actively partnering with cancer centers, molecular diagnostic companies, insurance companies, health funds, and pharma firms, presenting multiple high-value cross-sell and integration opportunities for AI-guided precision oncology solutions.

Post-acquisition expansion The acquisition of Oncompass Medicine in January 2026 expands Genomate's oncology capabilities and geographic footprint, creating upsell opportunities to existing customers and a stronger platform for cross-border deployments.

AI-powered offerings Recent launches such as the AI-powered second opinion service broaden the product suite and telehealth channel, enabling partnerships with healthcare providers seeking scalable, clinician-led decision support compatible with HSA/FSA reimbursement.

Recognition and signals Industry accolades including the Future Unicorn Award from DIGITALEUROPE and coverage by ASCO Breakthrough Innovations signal credibility and market validation, easing engagement with large healthcare buyers and CMOs.

Market-entry momentum Participation in selectUS A Investment Summit and ongoing multinational collaborations indicate growing US market traction and potential for expanded enterprise contracts with payers, pharma, and diagnostic networks.

Similar companies to Genomate Health

Genomate Health Tech Stack

Genomate Health uses 8 technology products and services including LinkedIn Ads, HubSpot Analytics, Apache Kafka, and more. Explore Genomate Health's tech stack below.

Media & News

Genomate Health's Email Address Formats

Genomate Health uses at least 1 email format:
Genomate Health Email FormatsExamplePercentage
First.Last@genomate.healthJohn.Doe@genomate.health
100%

Frequently Asked Questions

What is Genomate Health's official website and social media links?

Minus sign iconPlus sign icon
Genomate Health's official website is genomate.health and has social profiles on LinkedIn and Crunchbase.

How much revenue does Genomate Health generate?

Minus sign iconPlus sign icon
As of July 2026, Genomate Health's annual revenue is estimated to be $1M - $10M.

What is Genomate Health's NAICS code?

Minus sign iconPlus sign icon
Genomate Health's NAICS code is 923 - Administration of Human Resource Programs.

How many employees does Genomate Health have currently?

Minus sign iconPlus sign icon
As of July 2026, Genomate Health has approximately 30 employees across 3 continents, including Europe, North America and Asia. Key team members include Chief Technology Officer: P. F., Head Of Marketing & Brand: A. C. L. and Head Of People And Culture: O. P. Explore Genomate Health's employee directory with LeadIQ.

What industry does Genomate Health belong to?

Minus sign iconPlus sign icon
Genomate Health operates in the Health and Human Services industry.

What technology does Genomate Health use?

Minus sign iconPlus sign icon
Genomate Health's tech stack includes LinkedIn Ads, HubSpot Analytics, Apache Kafka, Amazon Web Services, Docker, Jenkins, Atlassian Jira and Webflow.

What is Genomate Health's email format?

Minus sign iconPlus sign icon
Genomate Health's email format typically follows the pattern of First.Last@genomate.health. Find more Genomate Health email formats with LeadIQ.

How much funding has Genomate Health raised to date?

Minus sign iconPlus sign icon
As of July 2026, Genomate Health has raised $10M in funding. The last funding round occurred on Apr 01, 2025 for $2M.

When was Genomate Health founded?

Minus sign iconPlus sign icon
Genomate Health was founded in 2022.
Genomate Health logo

Genomate Health

Health and Human ServicesMassachusetts, United States11-50 Employees

Genomate Health is a medical technology company based in Cambridge, Massachusetts, focused on developing computational models that integrate published scientific evidence and clinical experience with reasoning processes to guide cancer treatment. Its flagship product, Genomate, is described as an AI-driven solution that automates the compilation and synthesis of molecular information to support personalized, N-of-1 treatment decisions in precision oncology. The company operates in the Health and Human Services industry and collaborates with cancer centers, diagnostic companies, insurance entities, health funds, and pharmaceutical firms to broaden access to targeted cancer therapies.
Based in the Cambridge area, Genomate Health emphasizes precision medicine and computational reasoning to tailor therapy to individual disease profiles. The firm has pursued strategic growth through acquisitions and expansion into the U.S. market, including recent activity related to the Oncompass Medicine acquisition and the launch of an AI-powered second opinion service for physicians. The organization serves a global oncology ecosystem by aligning multiple stakeholders around personalized treatment options.

Section iconCompany Overview

NAICS Code
923 - Administration of Human Resource Programs
Founded
2022
Employees
11-50

Section iconFunding & Financials

  • $10M

    Genomate Health has raised a total of $10M of funding over 3 rounds. Their latest funding round was raised on Apr 01, 2025 in the amount of $2M as a Seed.

  • $1M - $10M

    Genomate Health's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.